Bayer Technology Services opens office in India
Bayer Technology Services GmbH, an affiliate of Germany's Bayer that offers solutions in the management of drug and chemicals plant, has opened its first regional office in India, enlarging its presence in the fast-growing Asian markets.
The inauguration took place only a few weeks after opening its regional hub in Dubai, United Arab Emirates. Customers benefit now from a strong Asian network steered by the regional BTS-headquarters in Shanghai, China, the firm says.
Achim Noack, managing director of BTS, said the services it now offers include all phases of investment projects, state-of-the-art technological solutions and optimization tools to improve energy efficiency or supply chains.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze